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Summary
Amphiphilic macromolecules containing a polysty-
rene-adherent peptide domain and a cell-repellent
poly(ethylene glycol) domain were designed, synthe-
sized, and evaluated as a cytophobic surface coating.
Such cytophobic, or cell-repellent, coatings are of in-
terest for varied medical and biotechnological applica-
tions. The composition of the polystyrene binding
peptide domain was identified using an M13 phage
display library. ELISA and atomic force spectroscopy
were used to evaluate the binding affinity of the amphi-
phile peptide domain to polystyrene. When coated
onto polystyrene, the amphiphile reduced cell adhe-
sion of two distinct mammalian cell lines and patho-
genic Staphylococcus aureus strains.
Introduction
Cytophobic, or cell-repellent, coatings are highly desir-
able for use in proteomics, cell culture technologies,
and biologically integrated medical devices because
the lifetime, reliability, and performance of many medi-
cal implants, diagnostics, and high-throughput screen-
ing formats are hindered by protein adsorption or cellu-
lar adhesion [1–10]. For example, bacterial cell
colonization and biofilm formation on implanted or in-
serted medical devices are common in clinical practice
and contribute to adverse outcomes. Catheters alone
account for hundreds of thousands of nosocomial infec-
tions each year, resulting in significant cost and burden
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vent biological fouling on surfaces include plasma treat-
ment, biotin-avidin conjugation strategies, phospho-
lipids, self-assembled monolayers on transition metal
coatings, chemically grafted poly(ethylene glycol)
(PEG), albumin adhesion, polyclonal antibodies, and an-
tibiotics [11–18]. Of these approaches, surface modifi-
cation with PEG has met with success for the prevention
of cell and protein adhesion [16, 19–27]. However, chem-
ically grafting this macromolecule to a surface often re-
quires surface preparation and multistep chemical pro-
cedures. Due to this and a variety of other issues, PEG
coatings have not achieved in vivo clinical use. Herein
we describe the synthesis of a prototypical peptide-
poly(ethylene glycol) amphiphile, the application of the
amphiphile to plastic surfaces, and the inhibition of sub-
sequent human and bacterial cell adhesion to the
coated surface.
Results and Discussion
These amphiphilic macromolecules possess two dis-
tinct domains: a hydrophilic PEG domain for cell repul-
sion and a relatively hydrophobic peptide domain se-
lected for specific surface binding. The specific
surface binding peptides were identified using peptide
phage display, a combinatorial biological technique
that selects high-affinity peptides for a specific target
through iterative screens [28–33]. Although its original
successes came from the recognition of biological tar-
gets and its uses for biotechnology and drug discovery
[34–37], phage display has recently proven to be a valu-
able technique for identifying specific peptides that bind
to a variety of inorganic and polymeric surfaces [38–48].
Phage display operates through affinity selection of
phage-encoded peptides [28–32]. In this study, two
peptide libraries (X6PX6 and X6YX6, where X represents
one of the 20 amino acids encoded by synthetic NNK co-
dons) were expressed separately on the pIII coat protein
and used to identify polystyrene binding peptides. This
combinatorial library (1010 total phage screened; 108
complexity) was screened against a polystyrene target
polymer using a well of a microtiter plate (CoStar, Corn-
ing). Polystyrene is widely used in cell culture and diag-
nostic technologies and is a suitable material with which
to demonstrate proof of concept due to its availability
and good optical qualities. It is important to note that
polystyrene plates available from laboratory suppliers
come in two main types: tissue culture polystyrene
(TCPS) and regular native polystyrene (PS), which was
the substrate used in the screen. The TCPS surfaces
have been treated with a high-energy process in order
to develop a surface that is more hydrophilic and nega-
tively charged, which are general characteristics condu-
cive to cellular attachment.
Once the PS binding phage clones were identified, the
base sequence of the DNA insert in the phage genome
was located and translated to yield the corresponding
amino acid sequence that was displayed on the phage
surface. Eighteen peptide sequences were identified
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696(Table 1; 1–18). The compositions of these peptides pro-
vide insight into which amino acids are important for PS
affinity. The percent occurrence for each residue in the
isolated sequences from the PS panning was compared
to those randomly picked from the initial library popula-
tion or from the theoretical amino acid frequency. Almost
all of the amino acids occur at frequencies similar to
those in their respective libraries; for example, approxi-
mately 1% occurrence was found for R, C, and Q; 3%
for N, H, Y, W, and M; and 7% for A, G, and P. In contrast,
I, T, V, and particularly K are strikingly underrepresented.
E and F are significantly enriched with 100% higher fre-
quency than expected. Among the aromatic residues
(F, Y, H, and W), F is the preferred hydrophobic residue.
The presence of hydrophilic residues likely balances the
hydrophobic properties of the selected peptides.
The relative binding strengths of these on-phage pep-
tides to PS were determined by treating the bound
phage with a horseradish peroxidase-anti-M13 mono-
clonal antibody conjugate and then with the chromo-
genic agent 2,20-azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid) (ABTS) (Table 1). Given the large error
associated with determining these values, we have
grouped the PS binders into three categories: weak, me-
dium, and strong. The affinity constant (kaff) for four
single peptides was estimated using an ELISA-type
assay (see the Supplemental Data available with this
article online) and included a relatively weak binder
(1), a medium binder (15), and two strong binders
(17 and 18). The values ranged from 6.7 3 104 to 7.3 3
106 M21, and are shown in Table 2. If the same experi-
ment is performed on TCPS, we observe an order of
magnitude decrease in the affinity constant. For exam-
ple, 18 had an affinity of 7.3 3 106 M21 on PS and
3.03 105 M21 on TCPS. As discussed earlier, the phage
library-screening assay was performed on native PS,
and the observed increase in the binding constant to
native versus TCPS highlights the ability to find peptide
sequences that possess affinity for a particular surface
even among closely related substrates.
Atomic force spectroscopy was used to further char-
acterize and quantify the adhesion strengths of a strong
binder, peptide 17, to PS. For these experiments, a C-ter-
minal cysteine derivative of peptide 17, 19, was prepared
and chemisorbed to gold-coated cantilevers. We then
measured the adhesion (pull-off) force between four
model surfaces (TCPS, native PS, methyl-terminated
self-assembled monolayer [SAM] on a gold surface,
and carboxylic acid-terminated SAM on a gold surface)
and the cantilever tip functionalized with peptide 19 un-
der aqueous conditions. In order to ensure intersample
consistency, the same cantilever was used to measure
the forces on all model surfaces. The spring constants
were determined by the thermal noise fluctuation
method. Figure 1 shows the distribution of adhesion
forces for the four model surfaces. An average adhesion
force of 6726 271 pN was obtained from approximately
250 force curves taken at several different locations on
the native PS (water contact angle 79) surface, and an
adhesion force of 606 41 pN was obtained from approx-
imately 550 force curves for the tissue culture PS (water
contact angle 56), again verifying the specificity of the
peptides to their target surfaces. To gauge the magni-
tude of this strong, noncovalent interaction, we per-formed additional experiments on hydrophilic (carbox-
ylic acid-terminated SAM, water contact angle 14) and
hydrophobic (methyl-terminated SAM, water contact an-
gle 114) surfaces and calculated forces of 93 6 42 pN
and 2502 6 1006 pN, respectively. On the acid-termi-
nated SAM, in which there should be minimal hydropho-
bic surface-peptide interactions, only a small adhesion
force was observed, while a large adhesion force was
measured on the methyl-terminated SAM. It is important
to note that hydrophobic interactions alone are not the
sole explanation for the observed forces, as the more hy-
drophilic acid SAM has a much lower contact angle than
the TCPS, yet the SAM surface has a higher average pull-
off value (p < 53 10238). In addition, we have conducted
experiments on unrelated surfaces with intermediate
surface energies and see little to no binding affinities
for these PS peptides. Adhesion forces in control exper-
iments between a PS surface and a bare gold-coated
cantilever tip without peptide modification were negligi-
ble when compared to the adhesion forces with the PS
binding peptide.
The peptide-poly(ethylene glycol) amphiphilic deriva-
tives, 21 and 22, were synthesized to evaluate whether
Table 1. Peptides Isolated from Phage Display Libraries X6PX6
and X6YX6 and Their Relative Binding Strengths, Normalized to the
ELISA OD of the Weakest Binder in the Panel of Peptides
Peptide Sequence RBS
No. Weak Binders 1–15
1 FRMDFDYLYPSLP
2 LNFMIFYLSLNPW
3 FSYSVSYAHPEGL
4 SVAFYDYLPTDLP
5 LSFSDFYFSEGSE
6 FAPMKSYGVSLPP
7 LFGPIEYTQFLAN
8 LFDAYWYSDTAMS
9 PASLELYENLVAG
10 GENFCPYSFFGCG
11 YLSLHAYESFGGS
12 FFGFDVYDMSNAL
13 FYMPFGPTWWQHV
Medium Binders 30–100
14 LPHLIQYRVLLVS
15 GFAWSSYLGTTVH
16 FLSFVFPASAWGG
Strong Binders >150
17 FFPSSWYSHLGVL
18 FFSFFFPASAWGS
19 FFPSSWYSHLGVL-SSG-C
20 FFPSSWYSHLGVL-SSG
21 FFPSSWYSHLGVL-SSG-PEG
22 FFSFFFPASAWGS-SSG-PEG
Italicized positions indicate nonvariable residues. RBS, relative
binding strengths (620%).
Table 2. Apparent Affinity Constants for Biotinylated Peptides
Binding to PS
Peptide No. kaff (M
21) Model Fit (R2)
FRMDFDYLYPSLPSSGK-biotin 1 6.62 3 104 0.997
GFAWSSYLGTTVHSSGK-biotin 15 1.78 3 105 0.996
FFPSSWYSHLGVLSSGK-biotin 17 1.86 3 106 0.996
FFSFFFPASAWGSSSGK-biotin 18 7.30 3 106 0.989
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697Figure 1. Adhesion Strength between Pep-
tide 19 and a Polystyrene Surface
Adhesion force distribution between a canti-
lever coated on one side with peptide 19
(FFPSSWYSHLGVL-SSG-C) and a carboxylic
acid-terminated self-assembled monolayer
on gold (blue), TCPS (red), a native PS sur-
face (yellow), and a methyl-terminated SAM
on gold (green).these amphiphiles would reside at the critical interfacial
site between the biologic and the plastic surface. We
first measured the critical aggregation concentration
(CAC) for 21 and 22 using a fluorescence titration
method with pyrene. The CAC was determined to be
11.2 and 8.2 mM for 21 and 22, respectively, confirming
the amphiphilicity of these macromolecules.
Assembly of this amphiphile on the surface should al-
ter the contact angle and reduce cell attachment if the
peptide is interacting with the surface and the PEG is di-
rected toward the cells. A cytophobic coating on a PS
surface is of practical interest because control of cell
adhesion on PS has many varied applications. We
measured the contact angle for untreated TCPS and
untreated native PS and compared those values to the
corresponding peptide 21- or 22-coated TCPS and na-
tive PS surfaces. The surfaces were washed prior to
measurement to remove any nonspecific interactions.
Contact angles provide a macroscopic measure of the
surface energy of the material-liquid interface. The con-
tact angle changed from 55.7 6 3.5 for uncoated TCPS
to 41.7 6 5.1 for 21-coated TCPS, and 27.1 6 4.8 for
a coating of 22. Likewise, the contact angle changed
from 79.0 6 3.6 for PS to 57.0 6 4.0 for 21-coated
PS and 19.8 6 3.0 for a coating of 22. The decrease
in the contact angle is consistent with hydrated PEGs
at the surface. These data indicate that both 21 and 22
can coat both types of polystyrene surfaces and change
their ‘‘wetabilities,’’ with the slightly stronger binder (22)
having a slightly larger effect.
The first cell attachment experiments were performed
with human umbilical vein endothelial cells (HUVECs),
because endothelial cells perform key roles in many of
the tissues where implanted devices would be utilized
such as the circulatory, pulmonary, renal, and digestive
systems. We have performed experiments with other
cell types, such as fibroblasts, and those data can be
found in the Supplemental Data. A 0.1 mg/ml solution
of 21 (21 mM) was prepared in phosphate-buffered saline
(PBS) and added to the wells of a 96-well PS plate, along
with a separate experiment of commercially available
PEG 3400 in PBS (0.07 mg/ml; 21 mM) and a control of
plain PBS. The coated plate was incubated at room tem-
perature for 6 hr and the peptide solution was removed
and the wells washed before cell seeding. Human endo-
thelial cells (100 ml; 1.5 3 104 cells per well) in mediumcontaining fetal bovine serum (FBS) were seeded onto
either the plain PBS-treated wells (N = 9), off-the-shelf
PEG 3400 wells (N = 9), or peptide-PEG amphiphile
FFPSSWYSHLGVL-SSG-PEG (21)-coated wells (N = 9).
After a 4 hr incubation period at 37C, the wells were vig-
orously washed three times with excess PBS and then
replenished with 100 ml of fresh medium and 20 ml of
an MTS (3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxyme-
thoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium) colori-
metric proliferation assay solution (Promega). After a
2 hr incubation, the absorbance of the wells was read
at 492 nm on a plate reader (Beckman Coulter AD
340C). The absorbance readings were converted to
cell counts by using control wells of known cell counts
run in parallel. The MTS assay showed the total cell
number reduced from 4819 6 668 for the PBS-treated
wells to 216 6 82 (p < 1 3 10213) upon coating the PS
with 21. As expected, due to the PEG’s inability to natu-
rally coat PS (see Supplemental Data), the unbound PEG
3400 did not afford a reduction in cell attachment, 7535
6 1720. Similar results were obtained using 21 with fi-
broblasts as well as with using amphiphile 22 with HU-
VECs (see Supplemental Data). Coating of the PS with
the peptide alone without PEG, 20, did not prevent cell
attachment (see Supplemental Data). Experiments
performed on TCPS plates show cellular attachment re-
ductions on the order of a few fold, but unlike above, do
not prevent all binding, likely due to the weakened pep-
tide interaction with the TCPS surface. New phage dis-
play experiments are underway to select peptide se-
quences with an increased level of affinity for the
TCPS surface to improve the binding of the amphiphile
to this substrate.
The encouraging mammalian cell results prompted the
evaluation of the cytophobic amphiphile as an antibacte-
rial coating. We investigated whether amphiphile 21
would inhibit adhesion of Staphylococcus aureus on
PS. AllS. aureus strains used in this study are clinical iso-
lates that form a classic biofilm complete with an exopo-
lysaccharide matrix.S. aureus is a part of the normal flora
but can also act as a pathogen by colonizing a variety of
medical implants [49]. It is known that the first step in
‘‘slime’’ biofilm formation is bacterial cell attachment
[50, 51]. Bacterial colonization of medical implants,
known as biofilm formation, can be modeled in vitro by
monitoring colonization of PS plates. Pathogenic strains
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698Figure 2. Prevention of Bacteria on Treated
Surfaces
(A) Representative photographs of S. aureus
seeded on treated PS surfaces. Bacterial at-
tachment was assessed for wells treated
with FFPSSWYSHLGVL-SSG-PEG (21), the
control peptide FFPSSWYSHLGVL-SSG (20),
and the untreated PBS-washed control. All
samples were run in duplicate. The intensity
of staining corresponds to the extent of bac-
terial colonization. Absorbance was mea-
sured on a plate reader and was 0.05 for
21, 1.64 for 20, and 1.07 for untreated PBS.
(B) Top-down, phase-contrast micrographs
of S. aureus seeded on PS surfaces treated
with FFPSSWYSHLGVL-SSG-PEG (21) or
PBS were assessed at 11 and 24 hr postin-
oculation.of S. aureus (13 107 cells per well) were allowed to form
a biofilm for 24 hr in PS plates coated with the amphi-
phile, 21, the peptide alone, 20, or the PBS untreated
control. The formation of the biofilm was monitored by
staining with the dye crystal violet (CV) as previously de-
scribed [50, 51]. As shown in Figure 2A, treatment with
amphiphile 21 significantly prevented colonization of
the modified surface byS. aureusas evidenced by the re-
duced CV staining. The staining data were confirmed by
direct microscopic inspection of the surface (Figure 2B).
The gray areas are the PS surface and the dark areas are
the S. aureus adhered to the PS. Similar results were ob-
served with ten additional clinical isolates of S. aureus
and two clinical isolates of coagulase-negative staphylo-
cocci (data not shown), suggesting that the effect ob-
served may be generalized to other clinically relevant
strains. The significant reduction in bacterial cell attach-
ment within the first 24 hr is encouraging.
Significance
The design, synthesis, and evaluation of nonfouling
peptide-PEG amphiphilic macromolecules are de-
scribed. Application of this coating to a PS surface re-
duces both mammalian and bacterial cell adhesion in
vitro. Both the PEG and PS binding peptide domains
are required in the macromolecule, as neither the pep-
tide nor the PEG alone inhibit cell binding when coated
on the surface. The coating process is facile and re-
quires only one relatively rapid incubation step to ap-
ply the amphiphile to a plastic surface. These cytopho-
bic coatings are highly modular and adaptable, as the
surface adhesion peptide can be interchanged with
other unique adhesion peptides specific for a discrete
surface. For example, we have also identified pep-tides, via phage display, with affinity for implant mate-
rials such as polycarbonate, nylon, stainless steel,
and titanium [47, 52]. Studies are ongoing using both
cytophobic and cytophilic coatings to direct cell at-
tachment and cellular activity on native and nonnatu-
ral surfaces. Importantly, these interfacial biomate-
rials provide further motivation to design, evaluate,
and optimize functional macromolecules for medical,
biotechnology, and pharmaceutical applications.
Supplemental Data
Supplemental Data include details of the experimental procedures
used in this article, and are available at http://www.chembiol.com/
cgi/content/full/13/7/695/DC1/.
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